معرفی
Professor Adam Devall is a distinguished academic at the University of Birmingham's College of Medical and Dental Sciences, holding the position of Professor of Maternal Health Clinical Trials and Metabolism and Systems Science. His research focuses on critical areas of maternal health, particularly miscarriage prevention, postpartum hemorrhage management, and maternal mortality reduction through rigorous clinical trials and evidence synthesis.
Devall's research interests center on maternal health clinical trials, with specific expertise in miscarriage prevention using progestogens, management of postpartum hemorrhage, and maternal mortality reduction strategies. His work combines clinical practice with methodological rigor, particularly in systematic reviews and meta-analyses that inform global health guidelines. He has made significant contributions to understanding risk factors for postpartum complications and developing evidence-based interventions to improve maternal outcomes worldwide.
His recent publications demonstrate a strong focus on high-impact maternal health issues, with numerous 2025 publications in top journals including The Lancet and American Journal of Obstetrics and Gynecology. These works examine sub-national variability in maternal mortality, causes of postpartum hemorrhage, and innovative interventions like the E-MOTIVE bundle for postpartum hemorrhage management. His research shows a clear trend toward implementation science and global health applications of maternal health interventions.
- European Journal of Human Genetics 2018
Professor Devall leads and collaborates on numerous significant research projects funded by major organizations including the Bill & Melinda Gates Foundation, NIHR, and Medical Research Council. His current projects include E-MASTER (diagnostic test accuracy for bleeding at cesarean section), long-term assessment of children from the PRISM trial, and the APT-Sepsis Programme for maternal sepsis prevention. These grants demonstrate his leadership in translating research into practical clinical applications that improve maternal health outcomes globally.
As part of the Institute of Metabolism and Systems Research, Devall contributes to a multidisciplinary team focused on women's metabolic health across the lifespan. His work intersects with clinical services at Birmingham Women's Hospital, creating a strong bench-to-bedside research pipeline that directly impacts patient care through evidence-based practice.
